Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?

Save

Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib

Is Cannabis Safe ?(6.7.2024)

Save

Dr. Jack Cush reviews FDA approval, news and journal articles -- Its the week before EULAR 2024 in Vienna!!

ACR’s Run At Goliath (PCPs) (5.31.2024)

Save

Dr. Jack Cush reviews the journal reports and articles from this past week on RheumNow.com. The ACR (and Cush) address their new website designed to educate PCPs and APP's - what do you think?

The Window Of Opportunity (5.24.2024)

Save

Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?

Don't You Know Who I Am (5.17.2024)

Save

Dr. Jack Cush reviews the news and journal reports from the past 2 weeks. This weeks question - Can we prevent gout, ILD or psoriasis?

My Cancelled Lecture (5.11.2024)

Save

In lieu of this weeks podcast, Dr. Jack Cush records his "Life Lessons (that keep changing) in Rheumatology Lecture. A lecture recently cancelled because some of this content was objectionable? (I dont think so!)

Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs

Save

The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.

Featured BSR Abstracts (5.3.2024)

Save

Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.

SLE Faculty Panel Q&A

Save

SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush

Tuesday Night Rheumatology- Mastering SLE

Save

Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Rethinking Pre-Clinical Disease in Lupus David Karp, MD Biology and Rx of Lupus Flares Michelle Kahlenberg, MD Current/Future Biomarkers in SLE Andrea Fava, MD

Current & Future Biomarkers in SLE - Dr. Andrea Fava

Save

Current & Future Biomarkers in SLE - Dr. Andrea Fava by Dr. Cush

Rheum Chapter Notes (4.26.2024)

Save

Rheum Chapter Notes (4.26.2024) by Dr. Cush